Armen Shanafelt Insider Trading
Get free email notifications about insider trading for Armen Shanafelt.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Armen Shanafelt. Armen Shanafelt is a Director in Protagonist Therapeutics, Inc ($PTGX) and a Director in AILERON THERAPEUTICS INC ($ALRN) and a Director in Aeglea BioTherapeutics, Inc. ($AGLE) and a Director in Surface Oncology, Inc. ($SURF).
Address: C/O LILLY VENTURES 115 W. WASHINGTON STREET, STE 1680 SOUTH INDIANAPOLIS 46204 IN
Companies in which Armen Shanafelt is an Insider
Aeglea BioTherapeutics, Inc.
Trading Symbol: AGLEIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Armen Shanafelt: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 09 2021
$AGLE Market Capitalization: $56.54M
$AGLE Previous Close: $4.19
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
AILERON THERAPEUTICS INC
Trading Symbol: ALRNIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Armen Shanafelt: Director
Holdings: 844,987 shares
Latest Transaction: Jun 25 2018
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Protagonist Therapeutics, Inc
Trading Symbol: PTGXIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Armen Shanafelt: Director
Holdings: 206,896 shares
Current Value: $3,703,438
Latest Transaction: Jun 12 2018
$PTGX Market Capitalization: $282.80M
$PTGX Previous Close: $17.90
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Surface Oncology, Inc.
Trading Symbol: SURFIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Armen Shanafelt: Director
Holdings: 3,181,817 shares
Latest Transaction: Jun 12 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Armen Shanafelt
Sentiment: All, AGLE, ALRN, PTGX, SURF
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 09 2021 | AGLE | Aeglea BioTherapeu ... | Shanafelt Armen | Director | Option Exercise | A | 6.80 | 40,000 | 272,000 | 40,000 | |
Jun 12 2020 | SURF | Surface Oncology, ... | Shanafelt Armen | Director | Option Exercise | A | 4.35 | 12,000 | 52,200 | 12,000 | |
Jun 10 2020 | AGLE | Aeglea BioTherapeu ... | Shanafelt Armen | Director | Option Exercise | A | 8.89 | 28,100 | 249,809 | 28,100 | |
Oct 03 2019 | SURF | Surface Oncology, ... | Shanafelt Armen | Director | Option Exercise | A | 1.17 | 16,531 | 19,341 | 16,531 | |
Jun 07 2019 | AGLE | Aeglea BioTherapeu ... | Shanafelt Armen | Director | Option Exercise | A | 6.33 | 12,400 | 78,492 | 12,400 | |
Jun 07 2019 | AGLE | Aeglea BioTherapeu ... | Shanafelt Armen | Director | Option Exercise | A | 6.33 | 12,400 | 78,492 | 12,400 | |
Jun 06 2019 | SURF | Surface Oncology, ... | Shanafelt Armen | Director | Option Exercise | A | 3.69 | 12,100 | 44,649 | 12,100 |